Transplantation Flashcards

1
Q

Two barriers of transplantation?

A
  • Rejection

- Tissue availability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the ABO system?

A
  • One of many blood group antigens
  • ABO - determined by a single gene encoding a glycosylation enzyme that modifies cell surface antigens
  • Allele A - modifies H into A
  • Allele B - modifies H into B
  • Allele O - encodes a non-functional enzyme - no modification
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are IgM antibodies?

A
  • Humans produce IgM antibodies against these carbohydrate structures - due to cross reaction with bacterial antigens
  • Humans produce IgM against blood group carbohydrate you lack
  • e.g., Group A has anti-B antibodies - so can’t be a donor.
    (pic of compatibility on laptop)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antibody compatibility - blood groups

A

A to B/ B to A = NO
A or B to O = YES
AB to any = YES - have no anti A or B antibodies
O to O only = YES - have anti A and B antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of transplantation (3 points)

A

Autograft - a graft or tissue from one anatomical site to another in the same individual - autologous / syngeneic e.g., skin graft - no problems

Allograft - transplant from unrelated individual of the same species - (homograft) - cells are termed allogeneic - e.g., kidney transplant

Xenograft - transplant using tissue from different species - cells are termed xenogeneic - e.g., use of other animals organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Types of rejection (3 types)

A

Acute rejection - Allografts - initially successful - without 10-14 days

Chronic rejection - with effective immunosuppression - allografts can last months/ years but degrade overtime

Hyperacute rejection - xenografts are rejected within hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the major barrier to transplantation?

A
  • MHC -Major histocompatibility complex

- How MHC was discovered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name a key feature of acute rejection

A
  • Animals given second allograft reject it even quicker
  • Is a memory type response - similar to vaccination
  • Is the T cells that mediate this rejection - MHC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the antigens in the allograft?

A
  • Antigens that differ between members of the same species - alloantigens - generate alloreactive response
  • MHC is major source of alloantigens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What provides the greatest source of diversity between donor and recipient? (1 point)

A
  • MHC molecules - as are the most polymorphic molecules in the human population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is the MHC polygenic, polymorphic and co-dominant?

A

Polymorphic - for a single gene - express both alleles from mother and father = co-dominant

Polygenic - express 3 different genes - all are expressed

= 6 different MHC class 1 genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are minor histocompatibility antigens?

A
  • other genes that can effect rejection

- any polymorphic proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is direct allorecognition?

A
  • A way the donor MHC is recognised as an alloantigen
  • E.G., Kidney transplant - immune cells are also transplanted as well as the organ - APCs, DCs - which migrate out of graft and to recipients lymph nodes - where they engage with T cells
  • Likely to be a major source of acute rejection
  • Greater the MHC mismatch - the faster and more strongly this occurs (more alloantigen is present)
  • Donor DCs in graft will eventually die - but rejection persists revealing a second mechanism of rejection - indirect allorecognition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is indirect allorecognition?

A

Allogeneic cells are processed directly by recipient APC and presented to recipient T cells

  • Means T cells cannot attack graft directly - (different MHC)
  • Instead - recepient T helper cells activate recipient macrophage (presenting graft peptides)
  • Macrophage causes inflammation and tissue damage - may induce graft antibody responses - alloantibodies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the T cell activate macrophage in indirect allorecognition?

A
  • Recipient macrophage ingests donor cell and presents allo-MHC derived peptide on recipient MHC
  • T cell is activated by the macrophage - and in return T cell provides signals (IFN-gamma) - which activate the macrophage to undergo respiratory burst
  • The activated macrophage damage the donor tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does tissue damage occur to the graft?

4 points

A
  • CD8 cells from direct recognition attack the graft directly
  • CD4 cells from indirect recognition help B cells to make anti-graft antibodies against graft
  • Antibodies bound to graft - lead to destruction via complement and via ADCC (macrophage and NK cells) - and aid further antigen presentation
  • CD4 T cells from indirect recognition help macrophage become activated and damage tissue
17
Q

Why are large numbers of T cells reactive to allo-MHC?

A
  • T cells are positively and negatively selected during development for those TCR can bind to self-MHC but do not react with self-peptide
  • T cells have not undergone thymic education yet for new tissue - but can still react quickly
  • Quick activation may be due to Allo-MHC-peptide complex binding efficiently to some recipient TCRs - and therefore triggering T cell activation
  • These Allo-MHC peptides are mimicing interactions between TCR and antigen
17
Q

What is thymic education?

A
  • T cells learning self from non-self
18
Q

2 ways of improving outcomes of transplantation

A
  1. Better MHC matching
  2. immunosuppressive drugs

target:
- key steps in T cell activation
- Used to deplete grafts of immune cells - Alemtuzumab =CAMPATH1 (worlds first humanized antibody)

19
Q

What causes hyperacute rejection from xenotransplant?

A
  • Alpha-Gal epitope is present in pigs - but humans have anti- alpha-Gal antibodies
  • Means pigs organs are rapidly coated in anti-alpha-Gal antibody - leading to complement -mediated destruction
  • Pre-existing immunity to this epitope makes rejection very rapid
20
Q

How can we minimise hyperacute rejection? (5 points)

A
  • Genetically engineer pigs - to express complement regulators - CD55, CD59 etc
  • Inactivate alpha1,3GT in pig germline
  • Disrupt endogenous MHC class 1 and class 2 expression
  • Add genes for negative regulators of immunity, clotting and inflammation
  • Use extensive immunosuppressive drugs/antibodies
21
Q

What are animal chimaeras?

A
  • Using pluripotent stem cells to generate organs
  • E.G., inject pluripotent stem cells into the embryo for rats deficient in pancreas development
  • New rats are born with a mouse pancreas - can use cells from this new mouse to transplant into diabetic mouse - and it reverses diabetes
  • Still requires immunosuppressives
  • Still possibility of rejection
22
Q

What is haemotopoietic stem cell transplantation (HSC)?

A
  • HSC - immune system is removed to allow repopulation with donor-derived HSC
  • For patients with immunodeficiency - e.g., following high dose chemotherapy
  • Recipient is allogenic to donor HSC
  • Rejection is aloo-rejection- known as graft versus host disease (GVHD) - potentially fatal
  • Allo-rejection can be beneficial in leukaemia - to get rid of residual leukaemia cells
23
Q

How is fetomaternal tolerance achieved?

A
  • Foetal-maternal interface does not express MHC2 - and has low MHC1 and specialised MHC1 called HLA-G - which inhibits NK cells
  • This limits allo-MHC reactions
  • Placenta is rich in factors that suppress effector T cells and promote inhibitory regulatory T cells
  • Uterine tissue also has mechanics to limit T cell attraction via chemokines
24
Q

What is the role of CD47 mechanism at the foetal-maternal interface?

A
  • CD47 is very highly expressed at interface between mother and foetus
  • CD47 has low MHC1 and 2 expression + high expression of CD47 anti-phagocytic signals - SIRPA
  • This has been shown to be true in other grafts too